Development of specific cell therapy to treat neurological diseases

• Unité de recherche: INNOSUISSE
• Numéro de projet: 48812.1 IP-LS
• Titre du projet anglais: Development of specific cell therapy to treat neurological diseases

Description succincte (Allemand)

Development of specific cell therapy to treat neurological diseases

Description succincte (Anglais)

Development of specific cell therapy to treat neurological diseases

Résumé des résultats (Abstract) (Allemand)

Chimeric structure of astrocytic specific chaperone and GliaPharm#s lead molecules will be designed by Prof. Raymond evaluated by Prof. Volterra and their potency as drug tested in GliaPharm#s laboratory in a preclinical mouse models including refractory epilepsy.